{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:58:17Z","timestamp":1770497897317,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s13300-024-01647-x","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T17:02:50Z","timestamp":1729702970000},"page":"2475-2487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unveiling the Spectrum of Glucose Variability: A Novel Perspective on FreeStyle Libre Monitoring Data"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-4050","authenticated-orcid":false,"given":"Adrian H.","family":"Heald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Stedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Warner-Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lleyton","family":"Belston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Paisley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Jotic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nebojsa","family":"Lalic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellena H.","family":"Habte-Asres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angus","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"issue":"6","key":"1647_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/BF01228130","volume":"14","author":"T Deckert","year":"1978","unstructured":"Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. survival, causes of death, and complications. Diabetologia. 1978;14(6):363\u201370.","journal-title":"Diabetologia."},{"issue":"14","key":"1647_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"Diabetes Control and Complications Trial Research Group, Nathan DM. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977\u201386.","journal-title":"N Engl J Med"},{"key":"1647_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/dc17-0636","volume":"40","author":"RW Beck","year":"2017","unstructured":"Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care. 2017;40:994\u20139.","journal-title":"Diabetes Care"},{"issue":"5","key":"1647_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1177\/1932296819883885","volume":"14","author":"L Heinemann","year":"2020","unstructured":"Heinemann L, Freckmann G, M\u00fcller-Wieland D, Kellerer M. Critical reappraisal of the time-in-range: alternative or useful addition to glycated hemoglobin? J Diabetes Sci Technol. 2020;14(5):922\u20137.","journal-title":"J Diabetes Sci Technol"},{"issue":"25","key":"1647_CR5","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"DM Nathan","year":"2005","unstructured":"Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643\u201353.","journal-title":"N Engl J Med"},{"issue":"8","key":"1647_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"The Diabetes Control and Complications Trial Research Group","year":"1995","unstructured":"The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44(8):968\u201383.","journal-title":"Diabetes"},{"issue":"10","key":"1647_CR7","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2337\/dc09-0109","volume":"32","author":"ES Kilpatrick","year":"2009","unstructured":"Kilpatrick ES, Rigby AS, Atkin SL. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care. 2009;32(10):1901\u20133.","journal-title":"Diabetes Care"},{"issue":"16","key":"1647_CR8","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa2205650","volume":"387","author":"L Leelarathna","year":"2022","unstructured":"Leelarathna L, Evans ML, Neupane S, Rayman G, Lumley S, Cranston I, Narendran P, Barnard-Kelly K, Sutton CJ, Elliott RA, Taxiarchi VP, Gkountouras G, Burns M, Mubita W, Kanumilli N, Camm M, Thabit H, Wilmot EG. Intermittently scanned continuous glucose monitoring for type 1 diabetes. N Engl J Med. 2022;387(16):1477\u201387.","journal-title":"N Engl J Med"},{"issue":"11","key":"1647_CR9","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2337\/dc18-1581","volume":"41","author":"RM Bergenstal","year":"2018","unstructured":"Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41(11):2275\u201380.","journal-title":"Diabetes Care"},{"issue":"4","key":"1647_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/dom.14638","volume":"24","author":"F Gomez-Peralta","year":"2022","unstructured":"Gomez-Peralta F, Choudhary P, Cosson E, Irace C, Rami-Merhar B, Seibold A. Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin. Diabetes Obes Metab. 2022;24(4):599\u2013608.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"1647_CR11","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.2337\/dc18-2479","volume":"42","author":"L Leelarathna","year":"2019","unstructured":"Leelarathna L, Beck RW, Bergenstal RM, Thabit H, Hovorka R, APCam11, AP@home04 and APCam08 Investigators. Glucose management indicator (GMI): insights and validation using guardian 3 and navigator 2 sensor data. Diabetes Care. 2019;42(4):e60\u20131.","journal-title":"Diabetes Care"},{"issue":"11","key":"1647_CR12","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.2337\/dc08-0864","volume":"31","author":"ES Kilpatrick","year":"2008","unstructured":"Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care. 2008;31(11):2198\u2013202.","journal-title":"Diabetes Care"},{"issue":"9","key":"1647_CR13","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1210\/jc.2015-3604","volume":"101","author":"SA Virk","year":"2016","unstructured":"Virk SA, Donaghue KC, Cho YH, et al. Association between HbA1c variability and risk of microvascular complications in adolescents with type 1 diabetes. J Clin Endocrinol Metab. 2016;101(9):3257\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"1647_CR14","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00125-007-0820-z","volume":"50","author":"ES Kilpatrick","year":"2007","unstructured":"Kilpatrick ES, Rigby AS, Goode K, Atkin SL. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia. 2007;50:2553\u201361.","journal-title":"Diabetologia"},{"issue":"10","key":"1647_CR15","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2337\/dc20-0016","volume":"43","author":"E Toschi","year":"2020","unstructured":"Toschi E, Slyne C, Sifre K, et al. The relationship between CGM-derived metrics, A1C, and risk of hypoglycemia in older adults with type 1 diabetes. Diabetes Care. 2020;43(10):2349\u201354.","journal-title":"Diabetes Care"},{"issue":"1","key":"1647_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2337\/dc19-0083","volume":"43","author":"J Zhu","year":"2020","unstructured":"Zhu J, Volkening LK, Laffel LM. Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes. Diabetes Care. 2020;43(1):22\u20138.","journal-title":"Diabetes Care"},{"issue":"2","key":"1647_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2337\/diacare.26.2.297","volume":"26","author":"SA Biankin","year":"2003","unstructured":"Biankin SA, Jenkins AB, Campbell LV, Choi KL, Forrest QG, Chisholm DJ. Target-seeking behavior of plasma glucose with exercise in type 1 diabetes. Diabetes Care. 2003;26(2):297\u2013301.","journal-title":"Diabetes Care"},{"issue":"2","key":"1647_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-003082","volume":"11","author":"D Montt-Blanchard","year":"2023","unstructured":"Montt-Blanchard D, S\u00e1nchez R, Dubois-Camacho K, Leppe J, Onetto MT. Hypoglycemia and glycemic variability of people with type 1 diabetes with lower and higher physical activity loads in free-living conditions using continuous subcutaneous insulin infusion with predictive low-glucose suspend system. BMJ Open Diabetes Res Care. 2023;11(2): e003082.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1647_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/ejsc.12062","volume":"24","author":"J Al Kandari","year":"2024","unstructured":"Al Kandari J, Al Ozairi E, Irshad M, Varghese A, Gray SR. Association of physical activity metrics with glucose variability in people with type 1 diabetes: A cross-sectional study. Eur J Sport Sci. 2024;24:210\u20136.","journal-title":"Eur J Sport Sci"},{"issue":"12","key":"1647_CR20","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/dc15-1188","volume":"38","author":"C Gorst","year":"2015","unstructured":"Gorst C, Kwok CS, Aslam S, et al. Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care. 2015;38(12):2354\u201369.","journal-title":"Diabetes Care"},{"issue":"3","key":"1647_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jdiacomp.2004.10.001","volume":"19","author":"IB Hirsch","year":"2005","unstructured":"Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications. 2005;19(3):178\u201381.","journal-title":"J Diabetes Complications"},{"issue":"3","key":"1647_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2337\/dc18-1444","volume":"42","author":"RW Beck","year":"2019","unstructured":"Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2019;42(3):400\u20135.","journal-title":"Diabetes Care"},{"issue":"12","key":"1647_CR23","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1600","volume":"40","author":"T Danne","year":"2017","unstructured":"Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631\u201340.","journal-title":"Diabetes Care"},{"key":"1647_CR24","doi-asserted-by":"publisher","first-page":"20063","DOI":"10.1038\/s41598-019-56541-5","volume":"9","author":"AJ Ahola","year":"2019","unstructured":"Ahola AJ, Mutter S, Forsblom C, et al. Meal timing, meal frequency, and breakfast skipping in adult individuals with type 1 diabetes \u2013 associations with glycaemic control. Sci Rep. 2019;9:20063.","journal-title":"Sci Rep"},{"issue":"1","key":"1647_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4093\/dmj.2022.0035","volume":"47","author":"D Dutta","year":"2023","unstructured":"Dutta D, Mohindra R, Mahajan K, Sharma M. Performance of fast-acting aspart insulin as compared to aspart insulin in insulin pump for managing type 1 diabetes mellitus: a meta-analysis. Diabetes Metab J. 2023;47(1):72\u201381.","journal-title":"Diabetes Metab J"},{"issue":"7","key":"1647_CR26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2337\/dc16-1771","volume":"40","author":"D Russell-Jones","year":"2017","unstructured":"Russell-Jones D, et al. Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial. Diabetes Care. 2017;40(7):943\u201350.","journal-title":"Diabetes Care"},{"key":"1647_CR27","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","volume":"391","author":"L Heinemann","year":"2018","unstructured":"Heinemann L, Freckmann G, Ehrmann D, et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018;391:1367\u201377.","journal-title":"Lancet"},{"key":"1647_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1089\/dia.2018.0079","volume":"20","author":"MD Breton","year":"2018","unstructured":"Breton MD, Patek SD, Lv D, et al. Continuous glucose monitoring and insulin informed advisory system with automated titration and dosing of insulin reduces glucose variability in type 1 diabetes mellitus. Diabetes Technol Ther. 2018;20:531\u201340.","journal-title":"Diabetes Technol Ther"},{"issue":"539\u2013550","key":"1647_CR29","first-page":"201","volume":"61","author":"P Oskarsson","year":"2017","unstructured":"Oskarsson P, Antuna R, Geelhoed-Duijvestijn P, Kr\u00f6ger J, Weitgasser R, Bolinder J. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial. Diabetologia. 2017;61(539\u2013550):201.","journal-title":"Diabetologia"},{"key":"1647_CR30","unstructured":"https:\/\/www.england.nhs.uk\/london\/wp-content\/uploads\/sites\/8\/2019\/07\/dia-FreeStyle-Libre-training-pack-for-HCP-and-patients-052018.pdf: accessed 30 March 2024"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01647-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-024-01647-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01647-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T05:11:03Z","timestamp":1731474663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-024-01647-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1647"],"URL":"https:\/\/doi.org\/10.1007\/s13300-024-01647-x","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adrian H Heald, Mike Stedman, John Warner-Levy, Lleyton Belston, Angela Paisley, Aleksandra Jotic, Nebojsa Lalic, Martin Gibson, Hellena H Habte-Asres, Martin Whyte, and Angus Forbes have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All participants were attending the clinic of one of the authors AHH. The FreeStyle Libre data are available in its entirety as part of their usual care for analysis by the clinical team. All patients were given the option to opt out of their data being analysed. Such data analysis in relation to clinical care is acceptable under UK research ethics guidance. We kept the patients whose data were fully analyzed informed in accordance with UK guidelines at . All data were full anonymised prior to analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}